Quick Answer
Emergent BioSolutions Inc. reported Stockholders Equity of $482.80 million for the year ending 2024.
- Emergent BioSolutions Inc. showed a decrease of -25.6% in Stockholders Equity from 2023 to 2024.
- This data is from Emergent BioSolutions Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2025.
- XBRL data for this metric is available from 2010 to 2024 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $377.25 million | Q3 2011: $381.29 million | Q1 2012: $409.59 million | Q2 2012: $419.69 million | Q3 2012: $427.04 million | Q1 2013: $435.59 million | Q2 2013: $449.53 million | Q3 2013: $467.31 million | Q4 2013: $489.62 million | Q1 2014: $477.50 million | Q2 2014: $487.77 million | Q3 2014: $513.14 million | Q1 2018: $881.30 million | Q2 2018: $938.40 million | Q3 2018: $966.60 million | Q1 2019: $987.30 million | Q2 2019: $988.90 million | Q3 2019: $1.04 billion | Q1 2020: $1.07 billion | Q2 2020: $1.20 billion | Q3 2020: $1.25 billion | Q1 2021: $1.52 billion | Q2 2021: $1.54 billion | Q3 2021: $1.52 billion | Q1 2022: $1.57 billion | Q2 2022: $1.51 billion | Q3 2022: $1.43 billion | Q1 2023: $1.20 billion | Q2 2023: $957.70 million | Q3 2023: $697.20 million | Q4 2023: $649.30 million | Q1 2024: $663.90 million | Q2 2024: $386.30 million | Q3 2024: $508.40 million | Q4 2024: $482.80 million | Q1 2025: $552.70 million | Q2 2025: $536.20 million | Q3 2025: $582.50 million.
- Over the full 13 years of available data (2010 to 2024), Emergent BioSolutions Inc.'s Stockholders Equity has grown by 30.7%.
- Historical annual values: Fiscal year 2024: $482.80 million | Fiscal year 2023: $649.30 million | Fiscal year 2022: $1.39 billion | Fiscal year 2021: $1.61 billion | Fiscal year 2020: $1.45 billion | Fiscal year 2019: $1.09 billion | Fiscal year 2018: $1.01 billion | Fiscal year 2017: $912.30 million | Fiscal year 2016: $596.20 million | Fiscal year 2013: $489.62 million | Fiscal year 2012: $441.36 million | Fiscal year 2011: $414.25 million | Fiscal year 2010: $369.46 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: